Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Hyperglycemia and elevated C‐reactive protein are independent predictors of hospital mortality in hospitalized COVID‐19 patients in South‐Kivu, eastern Democratic Republic of the Congo: A cross‐sectional study

View through CrossRef
AbstractBackground and AimThe coronavirus disease 2019 (COVID‐19) pandemic was a priority public health problem because of its high mortality rate. This study mainly aimed to determine factors associated with a poor outcome in COVID‐19 hospitalized patients in South‐Kivu, an eastern province of the Democratic Republic of the Congo (DRC).MethodsThis observational study retrospectively evaluated medical records of patients consecutively admitted for probable or confirmed COVID‐19 between May 01 and July 31, 2020 at the Hôpital Provincial Général de Référence de Bukavu (HPGRB), a tertiary hospital located in South‐Kivu. A binary logistic regression model was performed to determine the predictors of mortality.ResultsA total of 157 hospitalized COVID‐19 patients aged 57.7 (13.2) years were included in this study. Male gender (69.4%), older age (52.9%), medical history of diabetes (38.2%), and arterial hypertension (35.1%) were the most frequent risk factors. Most patients presented with fever (73.3%), cough (72.6%), and dyspnea (66.2%). Overall, 45.1% of patients died. Intrahospital mortality was significantly associated with advanced age [odds ratio, OR (95% confidence interval, CI) = 2.34 (1.06–5.38)], hypoxemia [OR (95% CI) = 4.67 (2.02–10.77)], hyperglycemia [OR (95% CI) = 2.14 (1.06–4.31)], kidney failure [OR (95% CI) = 2.82 (1.4–5.68)], hyperleukocytosis [OR (95% CI) = 3.33 (1.67–6.66)], and higher C‐reactive protein (CRP) levels [OR (95% CI) = 3.93 (1.93–8.01)]. After adjustment for various covariates, only higher CRP levels [OR (95% CI) = 3.23 (1.23–8.5)] and hyperglycemia [OR (95% CI) = 2.5 (1.02–6.11)] at admission were independently associated with mortality.ConclusionHyperglycemia and marked inflammatory syndrome were the major predictors of poor outcomes in patients hospitalized for COVID‐19 in South‐Kivu. These two factors should be quantified at hospital admission to establish the patient's prognosis.
Title: Hyperglycemia and elevated C‐reactive protein are independent predictors of hospital mortality in hospitalized COVID‐19 patients in South‐Kivu, eastern Democratic Republic of the Congo: A cross‐sectional study
Description:
AbstractBackground and AimThe coronavirus disease 2019 (COVID‐19) pandemic was a priority public health problem because of its high mortality rate.
This study mainly aimed to determine factors associated with a poor outcome in COVID‐19 hospitalized patients in South‐Kivu, an eastern province of the Democratic Republic of the Congo (DRC).
MethodsThis observational study retrospectively evaluated medical records of patients consecutively admitted for probable or confirmed COVID‐19 between May 01 and July 31, 2020 at the Hôpital Provincial Général de Référence de Bukavu (HPGRB), a tertiary hospital located in South‐Kivu.
A binary logistic regression model was performed to determine the predictors of mortality.
ResultsA total of 157 hospitalized COVID‐19 patients aged 57.
7 (13.
2) years were included in this study.
Male gender (69.
4%), older age (52.
9%), medical history of diabetes (38.
2%), and arterial hypertension (35.
1%) were the most frequent risk factors.
Most patients presented with fever (73.
3%), cough (72.
6%), and dyspnea (66.
2%).
Overall, 45.
1% of patients died.
Intrahospital mortality was significantly associated with advanced age [odds ratio, OR (95% confidence interval, CI) = 2.
34 (1.
06–5.
38)], hypoxemia [OR (95% CI) = 4.
67 (2.
02–10.
77)], hyperglycemia [OR (95% CI) = 2.
14 (1.
06–4.
31)], kidney failure [OR (95% CI) = 2.
82 (1.
4–5.
68)], hyperleukocytosis [OR (95% CI) = 3.
33 (1.
67–6.
66)], and higher C‐reactive protein (CRP) levels [OR (95% CI) = 3.
93 (1.
93–8.
01)].
After adjustment for various covariates, only higher CRP levels [OR (95% CI) = 3.
23 (1.
23–8.
5)] and hyperglycemia [OR (95% CI) = 2.
5 (1.
02–6.
11)] at admission were independently associated with mortality.
ConclusionHyperglycemia and marked inflammatory syndrome were the major predictors of poor outcomes in patients hospitalized for COVID‐19 in South‐Kivu.
These two factors should be quantified at hospital admission to establish the patient's prognosis.

Related Results

African Annals of Medicine reviewers in 2024
African Annals of Medicine reviewers in 2024
Le comité éditorial des Annales Africaines de Médecine tient à remercier les lecteurs qui ont analysé les manuscrits soumis pour publication au cours de l’année 2024 et ont ainsi d...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract Introduction Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Infant Mortality in Rural and Post-Conflict Areas in South Kivu, Eastern DR Congo: A Cross-Sectional Study 
Infant Mortality in Rural and Post-Conflict Areas in South Kivu, Eastern DR Congo: A Cross-Sectional Study 
Abstract Background: The infant mortality rate in the province of South Kivu remains one of the highest in the Democratic Republic of Congo (DR Congo). The aim of this stud...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
The burden of persistent symptoms after COVID-19 (long COVID): A Meta-analysis of controlled studies in children and adults
The burden of persistent symptoms after COVID-19 (long COVID): A Meta-analysis of controlled studies in children and adults
Abstract Background Previous meta-analyses estimating the prevalence of the post-COVID-19 condition (PCC) were confounded by the lack of negative control groups. This may r...
The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults
The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults
AbstractBackgroundPrevious meta-analyses estimating the prevalence of the post-COVID-19 condition (PCC) were confounded by the lack of negative control groups. This may result in a...
Correlation of COVID-19 Mortality with Clinical Parameters in an Urban and Suburban Nursing Home Population
Correlation of COVID-19 Mortality with Clinical Parameters in an Urban and Suburban Nursing Home Population
AbstractImportance and ObjectiveCOVID-19 has a high mortality rate amongst nursing home populations (26.4% nationally and 28.3% in New Jersey). Identification of factors influencin...

Back to Top